11 results
·
18ms
·
Sources: EU EUDAMED, US FDA
RFA-7 RADIATION FIELD ANALYZER
FDA 510(k)
FDA Class 1
·Radiology
DD cubeY® HL
FDA UDI
Dental Direkt GmbH·EDDIG8450071·The DD cubeY® HL zirconium dioxide milling blan...
n/a
FDA UDI
Hager & Meisinger Gesellschaft mit beschränkter Haftung·E0HM51008453140071·Rotary diamond instrument for dental application
LINK Instruments - Fixation instruments
FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575182572·Femoral stem prosthesis trial - Endo-Model Knee...
SURGICAL SUCTION INSTRUMENT-REUSABLE
FDA 510(k)
FDA Class 2
·General Hospital
NEISSERIA MENINGITIDIS GR. Y
FDA 510(k)
FDA Class 1
·Microbiology
GRANUFLO
FDA Adverse Event
Death
·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·May 20, 2014
TRANSMOTION MEDICAL, INC.
FDA Adverse Event
Other
·TRANSMOTION MEDICAL INC.·Product code GBB·November 13, 2012
TISSUE RETRIEVAL SYSTEM ANCHOR
FDA Adverse Event
Injury
·Product code GCJ·September 24, 2010
VITROS Chemistry Products LIPA Slides GEN 48, Coating 3235, REF/Catalog No. 166 8409 (60 slides per cartridge and 5 cartridges per box - 300 slides per box) and REF/Catalog No. 829 7749 (18 slides per cartridge and 5 cartridges per box - 90 slides per box). LIPA Slides are processed by higher volume (or mainframe) VITROS Chemistry Systems typically used in hospital laboratories. Ortho-Clinical Diagnostics, a Johnson & Johnson company. Ortho-Clinical Diagnostics, Inc. Rochester, NY 14626. 510(k) #: K845027 (18 January 1985). Shelf life: Cat. # 166 8409: 12/01/07, Cat. # 829 7749: 12/01/07-1/01/08
FDA Recall
Terminated
·Ortho-Clinical Diagnostics·Product code CHI·October 9, 2006
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012